[Evaluation of the level of depression and dementia in patients with primary chronic active epilepsy using the Dementia Mood Assessment Scale]. / Procena stepena depresije i demencije klinickom DMAS skalom kod bolesnika sa primarnom hronicnom aktivnom epilepsijom.

The study included 40 patients, aged 18-40 years with primary chronic active epilepsy, tested by clinical DMAS scale. We have found that the level of intelectual function damage (dementia) and mood (depression) rates depended on the long duration of epilepsy and the frequency of seizures, less on the frequency of specific EEG findings. Types of epileptic seizures and polytherapy influenced the depression and dementia rates the least in previous epilepsu treatment.

[The most frequent neurologic manifestations of Lyme disease]. / Najcesce neuroloske manifestacije lajmske bolesti.

The group of ten patients with Lyme disease, with neurological manifestation, was presented. Most of them were treated as patients with different neurological diseases until Lyme disease was confirmed. The evidence of Borrelia burgdorferi infection, specific blood immunoreactivity and cerebrospinal fluid were considered. Most of the patients were with meningoencephalitis. Neuroborreliosis clinical manifestations were heterogenous and atypical, making it difficult to diagnose.

[Treatment of peripheral paresis-paralysis of the facial nerve using corticosteroids]. / Lecenje periferne pareze-paralize facialisa kortikosteroidima.

The study comprised 113 patients with Bell's paresis-paralysis of the facial nerve. This group was considered as experimental while the control group involved patients with the same disease treated with oral corticosteroids. In both groups physical therapy has been applied from the very beginning of therapy. The results of the study have shown that in the group of patients treated with local corticosteroids the complete recovery was found in 82% of cases, partial in 14% and no signs of recovery in 4%. The mean time of clinical and electrophysiologic recovery was 17 days. In the control group of patients the complete recovery was found in 50%, partial in 37.5% and no improvement in 12.5%. The significant influence on the time and degree of recovery in both groups, and especially in the first group, has the time of starting the therapy; if the therapy started in the first week after the onset of the disease, the recovery was usually complete in the first group.